Riociguat For The Treatment Of Pulmonary Arterial Hypertension (pah): A Phase Iii Long-Term Extension Study (patent-2)

被引：0
|
作者：
Rubin, L. J. [1 ]
Galie, N. [2 ]
Grimminger, F. [3 ]
Grunig, E. [4 ]
Humbert, M. J. C. [5 ,6 ,7 ]
Jing, Z. -C. [8 ]
Keogh, A. M. [9 ]
Langleben, D. [10 ]
Fritsch, A. [11 ]
Kilama, M. Ochan [12 ]
Neuser, D. [11 ]
Ghofrani, H. -A. [3 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Univ Bologna, Inst Cardiol, Bologna, Italy
[3] Univ Hosp Giessen & Marburg, Dept Internal Med, Giessen, Germany
[4] Univ Heidelberg Hosp, Thoraxclin Heidelberg, Ctr Pulm Hypertens, Heidelberg, Germany
[5] Univ Paris Sud, Le Kremlin Bicetre, France
[6] INSERM, U999, Le Kremlin Bicetre, France
[7] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
[8] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Cardiopulm Circulat, Shanghai, Peoples R China
[9] St Vincents Hosp, Sydney, NSW, Australia
[10] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Ctr Pulm Vasc Dis, Montreal, PQ, Canada
[11] Bayer HealthCare, Global Clin Dev, Wuppertal, Germany
[12] Bayer HealthCare, Global Clin Dev, Milan, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3531
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
    Rubin, Lewis J.
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne
    Langleben, David
    Fritsch, Arno
    Menezes, Flavia
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1303 - 1313
  • [2] Riociguat for the Treatment of Pulmonary Arterial Hypertension (PAH): 1-Year Results from the PATENT-2 Long-term Extension Study
    Rubin, Lewis
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne
    Langleben, David
    Fritsch, Arno
    Menezes, Flavia
    Neuser, Dieter
    Ghofrani, Hossein
    CHEST, 2013, 144 (04)
  • [3] Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT--2 long-term extension
    Rubin, Lewis J.
    Galie, Nazzareno
    Grimminger, Friedrich
    Granig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne
    Langleben, David
    Fritsch, Arno
    Menezes, Flavia
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Effects of riociguat in treatment-naive versus pretreated patients with pulmonary arterial hypertension (PAH): 1-year results from the PATENT-2 long-term extension (LTE) study
    Jansa, P.
    Galie, N.
    Ghofrani, H. A.
    Humbert, M.
    Keogh, A. M.
    Langleben, D.
    Rubin, L. J.
    Vizza, D.
    Wang, C.
    Hoeper, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 10 - 10
  • [5] Riociguat for the treatment of pulmonary arterial hypertension (PAH): A responder analysis from the phase III PATENT-1 study
    Gruenig, Ekkehard
    Galie, Nazzareno
    Humbert, Marc
    Keogh, Anne M.
    Langleben, David
    Rubin, Lewis J.
    Speich, Rudolf
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial
    Ghofrani, Hossein-Ardeschir
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Huang, Yigao
    Jansa, Pavel
    Jing, Zhi-Cheng
    Kilpatrick, David
    Langleben, David
    Rosenkranz, Stephan
    Menezes, Flavia
    Fritsch, Arno
    Nikkho, Sylvia
    Humbert, Marc
    LANCET RESPIRATORY MEDICINE, 2016, 4 (05): : 361 - 371
  • [7] Health Outcome Assessment In Pulmonary Arterial Hypertension Patients Treated With Riociguat: 2-Year Results From The Patent-2 Long Term Extension Study
    Mathai, S. C.
    Odufowora-Sita, O.
    Minai, O. A.
    Busse, D.
    Brockman, B.
    Teal, S.
    Alston, T.
    Joish, V. N.
    Gater, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study
    Hoeper, Marius
    Ghofrani, Hossein-Ardeschir
    Halank, Michael
    Meyer, F. Joachim
    Staehler, Gerd
    Behr, Juergen
    Ewert, Ralf
    Fletcher, Monique
    Colorado, Pablo
    Nikkho, Sylvia
    Pena, Janethe de Oliveira
    Grimminger, Friedrich
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [9] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study
    Halank, Michael
    Hoeper, Marius M.
    Ghofrani, Hossein-Ardeschir
    Meyer, F. Joachim
    Staehler, Gerd
    Behr, Juergen
    Ewert, Ralf
    Fletcher, Monique
    Colorado, Pablo
    Nikkho, Sylvia
    Grimminger, Friedrich
    RESPIRATORY MEDICINE, 2017, 128 : 50 - 56
  • [10] Riociguat in Pulmonary Arterial Hypertension (PAH): Evaluation of Abbreviated Versions of the ESC/ERS Risk Assessment Tool in PATENT-2
    Humbert, M.
    Farber, H. W.
    Ghofrani, H.
    Busse, D.
    Meier, C.
    Hoeper, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345